Franca Fagioli
Overview
Explore the profile of Franca Fagioli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
308
Citations
4410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Apolito V, Ceolin V, Spadea M, Vitale R, Barone M, Tomatis A, et al.
J Cancer Res Clin Oncol
. 2025 Feb;
151(2):91.
PMID: 39994075
No abstract available.
2.
Tuli G, Munarin J, Quaglino F, Carbonaro G, Barat V, de Sanctis L, et al.
Pediatr Endocrinol Diabetes Metab
. 2025 Feb;
30(4):244-247.
PMID: 39963061
Objectives: To describe medullary thyroid cancer (MTC) onset in a boy affected previously by Langerhans cell histiocytosis (LCH) and review the literature for other reports of this association. Case Presentation:...
3.
Amoroso L, Fagioli F, Tondo A, Conte M, Badino C, Di Cataldo A, et al.
Support Care Cancer
. 2025 Feb;
33(3):153.
PMID: 39907793
Purpose: Patients with high-risk neuroblastoma (HR NB) frequently present with metastases in the bone marrow and bone. Approximately 15% of these patients are refractory to induction therapy, and 50% relapse....
4.
Braidotti S, Zudeh G, Franca R, Kiren V, Colombini A, Bettini L, et al.
Clin Transl Sci
. 2025 Feb;
18(2):e70136.
PMID: 39891427
High-dose methotrexate (HD-MTX) infusions are commonly used to consolidate remission in children with acute lymphoblastic leukemia (ALL). We investigate the potential role of candidate polymorphisms in SLCO1B1 (rs4149056 and rs2306283),...
5.
Luksch R, Palmerini E, Milano G, Paioli A, Asaftei S, Barretta F, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(4):e31551.
PMID: 39833645
Background: Several studies have shown that the intensity of treatment in Ewing sarcoma has an impact on outcome. The present trial tested the non-inferiority of intensive, shorter, induction chemotherapy (25 ...
6.
Carli D, Rondot F, Luca M, Campello A, Vallero S, Tirtei E, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682154
Background/objectives: Adrenocortical tumors (ACTs), including adrenocortical adenoma (ACA) and carcinoma (ACC), represent 0.3-0.4% of pediatric tumors. Beckwith-Wiedemann spectrum (BWSp) confer an increased risk of ACTs, but prognosis, management, and associated...
7.
Ince E, Galimard J, Ifversen M, Dalissier A, Szmit Z, Mirci-Danicar O, et al.
Haematologica
. 2024 Nov;
PMID: 39605204
Not available.
8.
Ceolin V, Spadea M, Apolito V, Saglio F, Fagioli F
J Pediatr Hematol Oncol
. 2024 Oct;
46(8):393-403.
PMID: 39469946
The prognosis of children with acute myeloid leukemia (AML) has improved incrementally over the last decades. However, at relapse, overall survival (OS) ∼40% to 50% and is even lower for...
9.
Peirone S, Tirtei E, Campello A, Parlato C, Guarrera S, Mareschi K, et al.
Front Oncol
. 2024 Oct;
14:1429833.
PMID: 39421445
Introduction: Ewing Sarcoma (EWS) has been reported in seven children with Down syndrome (DS). To date, a detailed assessment of this solid tumour in DS patients is yet to be...
10.
Rossi F, Valle M, Galeoto G, Tofani M, Berchialla P, Sciannameo V, et al.
Curr Oncol
. 2024 Sep;
31(9):5291-5306.
PMID: 39330018
Children/adolescents with cancer can develop adverse effects impacting gross motor function. There is a lack of gross motor function assessment tools that have been validated for this population. The aim...